Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, April 21st:

Annovis Bio, Inc. (ANVS Quick QuoteANVS - Free Report) : This clinical-stage drug platform company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.8% over the last 60 days.

Annovis Bio, Inc. Price and Consensus

Annovis Bio, Inc. price-consensus-chart | Annovis Bio, Inc. Quote

Annovis’ shares gained 14.5% over the last three months compared with the S&P 500’s advance of 3.5%. The company possesses a Momentum Score of A.

Annovis Bio, Inc. Price

Annovis Bio, Inc. price | Annovis Bio, Inc. Quote

Arcellx, Inc. (ACLX Quick QuoteACLX - Free Report) : This immunotherapy-focused clinical-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 173.5% over the last 60 days.

Arcellx, Inc. Price and Consensus

Arcellx, Inc. price-consensus-chart | Arcellx, Inc. Quote

Arcellx’s shares gained 10.5% over the last three months compared with the S&P 500’s advance of 3.5%. The company possesses a Momentum Score of B.

Arcellx, Inc. Price

Arcellx, Inc. price | Arcellx, Inc. Quote

Worthington Industries, Inc. (WOR Quick QuoteWOR - Free Report) : This industrial manufacturing company focused on value-added steel processing has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.9% over the last 60 days.

Worthington Industries, Inc. Price and Consensus

Worthington Industries, Inc. price-consensus-chart | Worthington Industries, Inc. Quote

Worthington’s shares gained 16.8% over the last three months compared with the S&P 500’s advance of 3.5%. The company possesses a Momentum Score of B.

Worthington Industries, Inc. Price

Worthington Industries, Inc. price | Worthington Industries, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.